← All trials
NCT07284433
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2026
- Primary completion
- Apr 27, 2029
- Completion date
- Nov 2, 2029
- First posted
- Dec 16, 2025
- Last posted
- Dec 16, 2025
- Enrollment
- 178
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- AvenCell Therapeutics, Inc.Lead sponsor
- AvenCellCollaborator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.